NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

NRx Pharmaceuticals Ownership Summary


NRx Pharmaceuticals is owned by 5.23% institutional investors, 9.77% insiders, and 85.00% retail investors. B group is the largest institutional shareholder, holding 14.02% of NRXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.25% of its assets in NRx Pharmaceuticals shares.

NRXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNRx Pharmaceuticals5.23%9.77%85.00%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
B group3.00M14.02%$6.39M
Vanguard group729.84K3.28%$1.98M
Advisorshares investments420.47K1.96%$895.60K
Commonwealth equity services397.43K1.86%$846.53K
Geode capital management310.11K1.45%$660.61K
Vanguard fiduciary trust169.58K0.79%$361.20K
Bleakley financial group117.20K0.55%$249.65K
Blackrock funding, inc. /de99.00K0.46%$210.86K
State street86.98K0.41%$185.28K
Xtx topco78.73K0.37%$167.70K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B group3.00M4.74%$6.39M
Advisorshares investments420.47K0.16%$895.60K
One wealth management investment & advisory services37.87K0.11%$102.64K
Headlands39.39K0.01%$83.91K
Axq capital, lp33.21K0.01%$70.74K
Bleakley financial group117.20K0.00%$249.65K
Xtx topco78.73K0.00%$167.70K
Virtu financial31.79K0.00%$68.00K
Ethos financial group15.90K0.00%$33.87K
Chicago partners investment group34.48K0.00%$102.40K

Top Buyers

HolderShares% AssetsChange
B group3.00M4.74%3.00M
Vanguard group729.84K-194.89K
Vanguard fiduciary trust169.58K0.00%169.58K
Advisorshares investments420.47K0.16%92.46K
Geode capital management310.11K-91.25K

Top Sellers

HolderShares% AssetsChange
Anson funds management lp---3.04M
Marshall wace, llp---189.14K
Renaissance---128.18K
Squarepoint ops---42.20K
Two sigma investments, lp---17.44K

New Positions

HolderShares% AssetsChangeValue
B group3.00M4.74%3.00M$6.39M
Vanguard fiduciary trust169.58K0.00%169.58K$361.20K
Xtx topco78.73K0.00%78.73K$167.70K
Headlands39.39K0.01%39.39K$83.91K
Global retirement partners39.30K0.00%39.30K$106.50K

Sold Out

HolderChange
Carolina wealth advisors-50.00
Simplex trading-690.00
Raymond james financial-2.57K
Townsquare capital-15.04K
Point72 asset management-15.98K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202510-62.96%1,162,134-70.63%51.07%3-83.33%3-
Sep 30, 20258-65.22%961,561-66.82%51.72%5-64.29%1-66.67%
Jun 30, 2025258.70%2,994,36832.46%189.62%1550.00%4-33.33%
Mar 31, 202523-14.81%2,260,524115.57%1313.86%10-37.50%6200.00%
Dec 31, 20242728.57%1,048,64246.80%923.53%1677.78%2-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv744.53K2.25%-
AdvisorShares Psychedelics ETF609.78K1.84%9.30K
Vanguard US Total Market Shares ETF193.42K1.23%-
Vanguard Institutional Extnd Mkt Idx Tr324.19K0.98%144.28K
Fidelity Extended Market Index172.50K0.52%63.51K
Abante Quant Value FI88.09K0.27%88.09K
KoAct US Brain Treatment Active41.02K0.26%41.02K
iShares Micro-Cap ETF66.54K0.20%-
Vanguard Instl Ttl Stk Mkt Idx InstlPls62.61K0.19%48.08K
Mandarine Global Microcap G EUR50.00K0.15%10.00K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2024Javitt Jonathan C Chairman and Chief ScientistBuy$46.80K
Aug 30, 2023Gorovitz Aaron-Buy$11.20K
Aug 30, 2023Hurvitz Chaim-Buy$20.13K
Aug 23, 2023Javitt Jonathan C Chief ScientistBuy$33.00K
Aug 22, 2023Javitt Jonathan C Chief ScientistBuy$64.40K

Insider Transactions Trends


DateBuySell
2024 Q41-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q34-

NRXP Ownership FAQ


Who Owns NRx Pharmaceuticals?

NRx Pharmaceuticals shareholders are primarily institutional investors at 5.23%, followed by 9.77% insiders and 85.00% retail investors. The average institutional ownership in NRx Pharmaceuticals's industry, Biotech Stocks , is 379.48%, which NRx Pharmaceuticals falls below.

Who owns the most shares of NRx Pharmaceuticals?

NRx Pharmaceuticals’s largest shareholders are B group (3M shares, 14.02%), Vanguard group (729.84K shares, 3.28%), and Advisorshares investments (420.47K shares, 1.96%). Together, they hold 19.27% of NRx Pharmaceuticals’s total shares outstanding.

Does Blackrock own NRx Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NRx Pharmaceuticals.

Who is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

B group is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.74% of its assets in 3M NRx Pharmaceuticals shares, valued at 6.39M$.

Who is the top mutual fund holder of NRx Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of NRx Pharmaceuticals shares, with 2.25% of its total shares outstanding invested in 744.53K NRx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools